Stefan Sacu

Prof

Medical University of Vienna
Country flagAustria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

Year:

2026

Year:

2026

Purpose: Previous studies have shown high reproducibility of population receptive field (pRF) mapping in young, healthy individuals. The present study examines whether such a level of reproducibility can also be achieved in patients suffering from retinal disease. Methods: Eleven patients with Stargardt disease and eleven patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) were examined in up to four sessions using high-resolution ultra-high field fMRI (Siemens Magnetom 7T) and microperimetry (MP, Nidek MP-3). Reproducibility of the pRF parameters within and between sessions was assessed using Spearman’s correlation coefficient. Results: Retinotopic maps calculated from ultra-high field MRI had excellent intra- and intersession reproducibility for pRF center position (median correlation between sessions for pRF center eccentricity: r = 0.91; polar angle: r = 0.90), but only modest reproducibility for pRF size (average correlation r = 0.39). Reproducibility was constant across sessions multiple weeks apart, indicating a long-term stability of the method. In addition, the results show that reproducibility is not related to the severity of retinal disease. Conclusion: The data demonstrate that retinotopic mapping of the primary visual cortex using ultra-high field MRI is a highly reproducible technique for the assessment of macular function in patients with retinal disease. The technique provides an unbiased quantification of retinal function adjunct to conventional clinical assessments and may assist the early diagnosis of retinal disease. In addition, it may be a valuable objective method for monitoring visual deficits during long-term therapeutic interventions or disease progression.

Year:

2026

Year:

2024

Background/Aims To determine the suitability of functional MRI (fMRI) as an objective measure of macular function following therapeutic intervention; conventional psychophysical measures rely heavily on patient compliance. Methods Twenty patients with neovascular age-related macular degeneration (nAMD) were studied with high-resolution fMRI, visual acuity, reading accuracy and speed, contrast sensitivity (CS) and microperimetry (MP) before and after 3 monthly intravitreal injections of ranibizumab. Population-receptive field retinotopic maps calculated from fMRI data were compared with psychophysical measures and optical coherence tomography. Results Best-corrected visual acuity (BCVA) responders (≥5 letters) showed an increase of 29.5% in activated brain area, while non-responders showed a decrease of 0.8%. Radial histograms over eccentricity allowed quantification of the absolute number of significant voxels and thus differences before and after treatment. Responders showed increases in foveal (α<0.5°) activation, while non-responders did not. Absence of intraretinal fluid and preservation of outer retinal layers was associated with higher numbers of active V1 voxels and better BCVA. Higher voxel numbers were associated with improved reading performance and, less marked, with BCVA, CS and MP. Conclusion The data show that retinotopic mapping using fMRI can successfully be applied objectively to evaluate the therapeutic response in nAMD patients treated with anti-vascular endothelial growth factor therapy. This demonstrates the ability of retinotopic mapping to provide an objective assessment of functional recovery at a cortical level; the technique can therefore be applied, in other degenerative macular diseases, to the assessment of potential therapeutic interventions such as gene therapy or cell replacement therapy.

Year:

2024

Purpose: To assess retinal function in areas of presumed fibrosis due to neovascular age-related macular degeneration (nAMD), using multimodal imaging and structure-function correlation. Design: Cross-sectional observational study. Methods: 30 eyes of 30 consecutive patients with nAMD with a minimum history of one year of anti-vascular endothelial growth factor therapy were included. Each patient underwent microperimetry (MP), color fundus photography (CFP), standard spectral-domain-based OCT (SD-OCT), and polarization sensitive-OCT (PS-OCT) imaging. PS-OCT technology can depict retinal fibrosis based on its birefringence. CFP, SD-OCT, and PS-OCT were evaluated independently for the presence of fibrosis at the corresponding MP stimuli locations. MP results and morphologic findings in CFP, SD-OCT, and PS-OCT were co-registered and analyzed using mixed linear models. Results: In total, 1350 MP locations were evaluated to assess the functional impact of fibrosis according to a standardized protocol. The estimated means of retinal areas with signs of fibrosis were 12.60 db (95% confidence interval: 10.44–14.76) in CFP, 11.60 db (95% COI: 8.84–14.36) in OCT, and 11.02 db (95% COI 8.10–13.94) in PS-OCT. Areas evaluated as subretinal fibrosis in three (7.2 db) or two (10.1 db) modalities were significantly correlated with a lower retinal sensitivity than a subretinal fibrosis observed in only one (15.3 db) or none (23.3 db) modality (p < 0.001). Conclusions: CFP, SD-OCT and PS-OCT are all suited to detect areas of reduced retinal sensitivity related to fibrosis, however, a multimodal imaging approach provides higher accuracy in the identification of areas with low sensitivity in MP (i.e., impaired retinal function), and thereby improves the detection rate of subretinal fibrosis in nAMD.

Year:

2024

Purpose Neurovascular coupling impairment and inner retinal layer thinning are early detectable retinal changes in diabetes, and both worsen during progression of diabetic retinopathy (DR). However, direct interactions between these features have not been investigated so far. Therefore, we aimed to analyze associations between the retinal functional hyperemic response to light stimulation and the thickness of individual neuroretinal layers in eyes with early non-proliferative DR. Methods Thirty patients with type 1 diabetes featuring mild ( n = 15) or moderate ( n = 15) non-proliferative DR and 14 healthy subjects were included in this cross-sectional study. Retinal vessel diameters were measured before and during illumination with flickering light using a dynamic vessel analyzer. Individual layer thickness in the macula was analyzed from spectral domain optical coherence tomography. Results Flicker light-induced vessel dilation was significantly reduced in patients compared to healthy controls (veins: 3.0% vs. 6.1%, p < 0.001; arteries: 1.3% vs. 5.1%, p = 0.005). Univariately, the response in retinal veins of diabetes patients correlated significantly with ganglion cell layer (GCL) thickness ( r = 0.46, p = 0.010), and negatively with hemoglobin A1c (HbA1c) levels ( r =-0.41, p = 0.023) and age ( r =-0.38, p = 0.037), but not with baseline diameters, glucose levels, or diabetes duration. In a multiple regression model only GCL thickness ( p = 0.017, β = 0.42) and HbA1c ( p = 0.045, β=-0.35) remained significantly associated with the vascular flicker light response. Conclusion The results indicate that thinner GCL and worse glycemic control both contribute to reduced retinal neurovascular coupling in patients with clinical signs of DR. Progression of neurovascular dysfunction in DR might be related to structural degeneration of the neurovascular complex in the inner retina.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (21)

Christoph Hitzenberger

Vice Chair / Prof

Medical University of Vienna

AUSTRIA
View details

Markus Schranz

Medical University of Vienna

AUSTRIA
View details

Philip Rosenfeld

Professor of Ophthalmology

University of Miami Health System

UNITED STATES
View details

Samantha Fraser‐Bell

University of Sydney

AUSTRALIA
View details

Berthold Pemp

Director Neuro-Ophthalmology Service

Medical University of Vienna

AUSTRIA
View details

Arshad Khanani

University of Nevada

UNITED STATES
View details

Carlo Cagini

Direttore Clinica Oculistica

University of Perugia

ITALY
View details

Annabelle Okada

Professor

School of Medicine, Kyorin University

JAPAN
View details

Andreas Pollreisz

Associate Professor

Medical University of Vienna

AUSTRIA
View details

Hrvoje Bogunović

Tenure Track Faculty

Medical University of Vienna

AUSTRIA
View details

Christian Windischberger

Universität Wien

AUSTRIA
View details

Heiko Stino

Medical University of Vienna

AUSTRIA
View details

Ursula Schmidt-Erfurth

Adjunct Professor

Northwestern University

UNITED STATES
View details

Richard P. Gale

Professor of Ophthalmology

University of York

UNITED KINGDOM
View details

Reinhard Told

Medical University of Vienna

AUSTRIA
View details

Maciej Gawęcki

head of Dept

-

POLAND
View details

Bianca S Gerendas

Managing Director

Medical University of Vienna

AUSTRIA
View details

Michael Woletz

Medical University of Vienna

AUSTRIA
View details

Gabor Deak

Medical University of Vienna

AUSTRIA
View details

Bartosz Sikorski

Nicolaus Copernicus University

POLAND
View details

Gregor Reiter

Medical University of Vienna

AUSTRIA
View details